Sepsitron
Singapore
About Sepsitron
Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Pre-Seed (Nov 2019)
- Website: sepsitron.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Hardware, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sepsitron-168398 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.